Search
Descriptor in English: Ancitabine
Descriptor in Spanish: Ancitabina
Descriptor in Portuguese: Ancitabina
Descriptor in French: Ancitabine
Entry term(s): Anhydro-Ara-C
Cyclo C
Cyclo-C
CycloC
Cyclocytidine
NSC 145,668
NSC 145668
NSC-145,668
NSC-145668
NSC145,668
NSC145668
U 33,624A
U 33624A
U-33,624A
U-33624A
U33,624A
U33624A
Tree number(s): D03.383.742.680.245.453.050
D13.570.065.300.050
D13.570.685.245.453.050
Scope note: Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
History Note: 96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90)
DeCS UI: 3524
Descriptor UI: D003504
Date Established: 1991/01/01
Date of Entry: 1976/04/13
Revision Date: 2016/05/27
Ancitabine - Preferred
Concept UI M0005461
Scope note Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
Preferred term Ancitabine
Entry term(s) Anhydro-Ara-C
Cyclocytidine
NSC-145,668 - Narrower
Concept UI M0376273
Preferred term NSC-145,668
Entry term(s) NSC 145,668
NSC 145668
NSC-145668
NSC145,668
NSC145668
U-33,624A - Narrower
Concept UI M0372336
Preferred term U-33,624A
Entry term(s) U 33,624A
U 33624A
U-33624A
U33,624A
U33624A
Cyclo-C - Narrower
Concept UI M0005462
Preferred term Cyclo-C
Entry term(s) Cyclo C
CycloC



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey